Who Supplies Bevacizumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Bevacizumab exports, with 196+ registered manufacturers shipping to buyers across 100+ countries — yet a handful of companies dominate the shipments. DR.REDDY'S LABORATORIES LTD holds the largest share at 24.5% (export value: $11.5M). Close behind, BIOCON BIOLOGICS INDIA LIMITED (18.3%, $8.6M). DR REDDY S LABORATORIES LTD (9.9%, $4.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Bevacizumab? Top Manufacturers & Their Buyers
Flow of Bevacizumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Bevacizumab Supplier Network — Key Market Intelligence
The Bevacizumab export market from India is led by DR.REDDY'S LABORATORIES LTD, which alone commands a 24.5% share, shipping $11.5M worth of product across 131 shipments. The second-largest exporter, BIOCON BIOLOGICS INDIA LIMITED, contributes $8.6M (18.3%) to the overall market. Combined, the top two suppliers alone account for 42.8% of all Bevacizumab exports, indicating a relatively concentrated supply base.
Across all 196 tracked manufacturers, the total Bevacizumab export value stands at $46.9M from 1.4K shipments. The market average shipment value is $33.3K. The single largest buyer relationship in terms of trade value is JSC R-PHARM, receiving $9.6M worth of product.
The combined buyer network spans 19 named purchasing companies, including JSC R-PHARM, DR.REDDYS LABORATORIES SAS, STATE TRADING ORGANIZATION PLC, BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the first-largest Bevacizumab exporter from India, with a market share of 24.5% and a total export value of $11.5M across 131 shipments. Their average shipment value of $87.6K is above the market average of $33.3K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 84.0% of this supplier's tracked business. Top customers include:
• JSC R-PHARM — $9.6M across 110 shipments (84.0% of this supplier's total exports)
• DR.REDDYS LABORATORIES SAS — $833.4K across 10 shipments (7.3% of this supplier's total exports)
• DR.REDDYS LABORATORIES SAS — $492.4K across 6 shipments (4.3% of this supplier's total exports)
• NA — $338.0K across 4 shipments (2.9% of this supplier's total exports)
• STATE TRADING ORGANIZATION PLC — $169.0K across 2 shipments (1.5% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $87.6K is 163% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.
2BIOCON BIOLOGICS INDIA LIMITED
BIOCON BIOLOGICS INDIA LIMITED is the second-largest Bevacizumab exporter from India, with a market share of 18.3% and a total export value of $8.6M across 46 shipments. Their average shipment value of $186.6K is above the market average of $33.3K, suggesting premium or bulk contract pricing.
BIOCON BIOLOGICS INDIA LIMITED serves 5 named buyers in our database. BIOCON BIOLOGICS UK LIMITED is the dominant customer, accounting for 57.2% of this supplier's tracked business. Top customers include:
• BIOCON BIOLOGICS UK LIMITED — $4.9M across 26 shipments (57.2% of this supplier's total exports)
• XXOCOXXBIOXXGICXXUK XXMITXX — $3.0M across 16 shipments (34.6% of this supplier's total exports)
• XXOSWXXS PXXRMAXXUTI — $419.0K across 2 shipments (4.9% of this supplier's total exports)
• XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX — $202.1K across 1 shipments (2.4% of this supplier's total exports)
• XXOSIXXLARXXNEWXX LI — $88.3K across 0 shipments (1.0% of this supplier's total exports)
Key Insight: BIOCON BIOLOGICS INDIA LIMITED's per-shipment value of $186.6K is 460% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.
3DR REDDY S LABORATORIES LTD
DR REDDY S LABORATORIES LTD is the third-largest Bevacizumab exporter from India, with a market share of 9.9% and a total export value of $4.6M across 14 shipments. Their average shipment value of $331.8K is above the market average of $33.3K, suggesting premium or bulk contract pricing.
DR REDDY S LABORATORIES LTD serves 1 named buyer in our database. JSC R-PHARM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• JSC R-PHARM — $4.6M across 14 shipments (100.0% of this supplier's total exports)
Key Insight: DR REDDY S LABORATORIES LTD's per-shipment value of $331.8K is 896% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.
4RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Bevacizumab exporter from India, with a market share of 4.0% and a total export value of $1.9M across 73 shipments. Their average shipment value of $25.8K is below the market average of $33.3K, reflecting a high-volume, competitive pricing strategy.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SEAN DOMINICAN SRL — $762.5K across 30 shipments (40.5% of this supplier's total exports)
• WELL AND TECH MEDICAL LTD. — $525.5K across 20 shipments (27.9% of this supplier's total exports)
• LEVANT PULSE — $339.2K across 13 shipments (18.0% of this supplier's total exports)
• PHARMACHEM PRIVATE L — $150.3K across 6 shipments (8.0% of this supplier's total exports)
• OCTELLE CO., LTD — $105.2K across 4 shipments (5.6% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (73 shipments) at a per-shipment value of $25.8K, indicating a broad distribution network with many smaller, regular orders.
5ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the fifth-largest Bevacizumab exporter from India, with a market share of 3.8% and a total export value of $1.8M across 21 shipments. Their average shipment value of $85.0K is above the market average of $33.3K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the dominant customer, accounting for 92.9% of this supplier's tracked business. Top customers include:
• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $1.7M across 20 shipments (92.9% of this supplier's total exports)
• FARMEDICAL S.R.L. — $83.5K across 1 shipments (4.7% of this supplier's total exports)
• D. K. M. PHARMACEUTI — $19.8K across 0 shipments (1.1% of this supplier's total exports)
• RIPPLE PHARMACEUTICA — $14.1K across 0 shipments (0.8% of this supplier's total exports)
• RIPPLE PHARMACEUTICA — $9.6K across 0 shipments (0.5% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $85.0K is 155% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.
6DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the fifth-largest Bevacizumab exporter from India, with a market share of 2.5% and a total export value of $1.2M across 10 shipments. Their average shipment value of $117.5K is above the market average of $33.3K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. DR.REDDYS LABORATORIES SAS is the dominant customer, accounting for 72.7% of this supplier's tracked business. Top customers include:
• DR.REDDYS LABORATORIES SAS — $853.9K across 7 shipments (72.7% of this supplier's total exports)
• DR.REDDYS LABORATORIES SAS — $110.3K across 1 shipments (9.4% of this supplier's total exports)
• DR REDDYS LABORATORI — $105.5K across 1 shipments (9.0% of this supplier's total exports)
• STATE TRADING ORGANIZATION PLC — $93.3K across 1 shipments (7.9% of this supplier's total exports)
• HYPERPHARM LTD — $11.8K across 0 shipments (1.0% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $117.5K is 253% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Bevacizumab Flows
Once Bevacizumab leaves the manufacturing plants of companies like DR.REDDY'S LABORATORIES LTD and BIOCON BIOLOGICS INDIA LIMITED, it travels to 5 destination markets with a combined import value of $46.9M. Russia absorbs the largest share at 50.3% ($23.6M), followed by Netherlands (14.3%) and Colombia (7.9%).
In Russia — the top destination — named importers include JSC R-PHARM, JSC R PHARM. In Netherlands, key buyers are BIOCON BIOLOGICS UK LIMITED, XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX.
This geographic spread reflects Bevacizumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Bevacizumab Go? Top Importing Countries & Their Buyers
Trade flow of Bevacizumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Bevacizumab imports from India, with a total trade value of $23.6M across 66 shipments — representing a 50.3% share of all Bevacizumab exports. The average shipment value of $357.6K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Bevacizumab importers in Russia: JSC R-PHARM is the largest buyer, accounting for 79.1% ($18.7M) of this market's total imports.
• JSC R-PHARM — $18.7M (79.1% of Russia's total)
• JSC R PHARM — $4.9M (20.8% of Russia's total)
Key Insight: Russia's per-shipment average of $357.6K (973% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Bevacizumab imports from India.
2Netherlands
Netherlands ranks as the second-largest destination for Bevacizumab imports from India, with a total trade value of $6.7M across 20 shipments — representing a 14.3% share of all Bevacizumab exports. The average shipment value of $336.5K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Bevacizumab importers in Netherlands: BIOCON BIOLOGICS UK LIMITED is the largest buyer, accounting for 72.9% ($4.9M) of this market's total imports.
• BIOCON BIOLOGICS UK LIMITED — $4.9M (72.9% of Netherlands's total)
• XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX — $202.1K (3.0% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $336.5K (910% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Bevacizumab imports from India.
3Colombia
Colombia ranks as the third-largest destination for Bevacizumab imports from India, with a total trade value of $3.7M across 32 shipments — representing a 7.9% share of all Bevacizumab exports. The average shipment value of $116.2K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Bevacizumab importers in Colombia: DR.REDDYS LABORATORIES SAS is the largest buyer, accounting for 51.0% ($1.9M) of this market's total imports.
• DR.REDDYS LABORATORIES SAS — $1.9M (51.0% of Colombia's total)
• DRREDDYS LABORATORIES SAS — $853.9K (23.0% of Colombia's total)
• DR. REDDYS LABORATORIES SAS — $777.6K (20.9% of Colombia's total)
Key Insight: Colombia's per-shipment average of $116.2K (249% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Bevacizumab imports from India.
4Mexico
Mexico ranks as the fourth-largest destination for Bevacizumab imports from India, with a total trade value of $1.7M across 3 shipments — representing a 3.6% share of all Bevacizumab exports. The average shipment value of $562.3K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bevacizumab importers in Mexico: ZYDUS PHARMACEUTICALS M?XICO S.A. D is the largest buyer, accounting for 98.3% ($1.7M) of this market's total imports.
• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $1.7M (98.3% of Mexico's total)
Key Insight: Mexico's per-shipment average of $562.3K (1588% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Bevacizumab imports from India.
5Venezuela
Venezuela ranks as the fifth-largest destination for Bevacizumab imports from India, with a total trade value of $1.4M across 2 shipments — representing a 3.1% share of all Bevacizumab exports. The average shipment value of $721.3K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bevacizumab importers in Venezuela: WELL AND TECH MEDICAL LTD. is the largest buyer, accounting for 36.4% ($525.5K) of this market's total imports.
• WELL AND TECH MEDICAL LTD. — $525.5K (36.4% of Venezuela's total)
Key Insight: Venezuela's per-shipment average of $721.3K (2065% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Bevacizumab imports from India.
People Also Ask — Bevacizumab Supplier & Trade Network
Who are the top suppliers of Bevacizumab from India?+
Which companies buy Bevacizumab from Indian manufacturers?+
Where does Bevacizumab exported from India go?+
What is the market share of the top Bevacizumab supplier from India?+
What is the average shipment value for Bevacizumab exports from India?+
Is Bevacizumab manufactured in India and exported globally?+
Which country imports the most Bevacizumab from India?+
Who are the buyers of Bevacizumab in Netherlands?+
How concentrated is the Bevacizumab supplier market in India?+
How do I find verified buyers for Bevacizumab in specific countries?+
Bevacizumab Trade Network — Key Takeaways
- 1DR.REDDY'S LABORATORIES LTD is India's dominant Bevacizumab exporter with a 24.5% market share and $11.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 196 suppliers collectively account for 63.0% of all tracked Bevacizumab exports, with a combined trade value of $46.9M.
- 3Russia is the largest destination market, absorbing 50.3% of India's Bevacizumab exports ($23.6M). Netherlands (14.3%) and Colombia (7.9%) follow.
- 4With 1.4K total shipments averaging $33.3K each, the Bevacizumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include JSC R-PHARM, DR.REDDYS LABORATORIES SAS, BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 100 countries
Network value: $46.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Bevacizumab.
- 2.Flow Mapping: 196 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,408 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,408 Verified Shipments
196 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists